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"Primum non nocere:" Above all, do no harm (1). 
Almost a decade ago, at the International Congress 
of the Transplantation Society held in Helsinki in 1986, 
the authors held a debate on the issue of utilization of 
living-donor organs for kidney transplantation. One of 
us (FTR) upheld the pro side (1), summarizing the large 
body of objective data which pOint to the safety of living-
donor kidney transplantation, and to the major benefits 
which can be accrued by the donor in terms of enhanced 
feelings of self-esteem and self-worth at the conclusion 
of this heroic act. On the con side, Starzl (2) reviewed 
the broad spectrum of potential complications and even 
mortality «0.1%) which may result from the donor op-
eration, and noted how, in spite of the most stringent 
precautions to protect the donor, this operation can never 
be totally safe for the donor. Starzl reviewed, in particu-
lar, the potentially devastating effects of a living-organ 
donor tragedy upon the donor's family, the operating sur-
geon, and the transplantation team. The probability that 
the living-organ donation effort might detract from the 
energy pool available for cadaver-donor organ retrieval 
appeared to constitute an additional worrisome compo-
nent of this effort. Both authors agreed on the need to 
ensure that every effort be made as to the sincerity and 
spontaneity of the donation, and that the donation could 
not be a consequence of family pressure of financial trans-
plantation. The large and steadily increasing population 
of patients with end-stage renal disease maintained on 
hemodialysis, who are exposed to a significantly higher 
mortality risk (21 % per yr) while on dialysis (3) appeared 
to be the primary factor in this equation. When com-
pared with the immeasurably better quality of life pro-
duced by renal transplantation, with a far lower mortality, 
the security of donor organs from brain-dead donors ap-
peared to constitute an irrefutable argument in favor of 
living-donor transplantation. Recent progress in clinical 
transplantation has made it possible to extend the utili-
zation of living donors to pancreatic (4) and liver trans-
plantation (5) to save the lives of desperately ill patients 
- often children, who lack the alternative option of 
hemodialysis. This has further complicated the equa-
tion. 
In the intervening years, the cascade of arguments 
used by one of us (FTR) to support living-organ donation 
has evolved and prompted a review of this position on 
living donation. As more years have passed, and the 
transplant team's experience has evolved, the pro posi-
tion seems to have become ever less attractive. This is 
not to say that this author (FTR) believes that living-or-
gan donation should be eliminated altogether. We are 
both (FTR and TES) convinced, however, that the pro-
cedure must be planned with the utmost circumspection 
and respect and with the fullest possible information given 
to the prospective donor regarding all potential risks and 
hazards. These involve not only the possible failure of 
the transplanted organ in the reCipient but also the wide 
spectrum of risks associated with the operative proce-
dure. These risks escalate geometrically for segmental 
pancreas, liver, or lung donations. Indeed, the latter pro-
cedures involve extremely complicated surgical tech-
niques and are fraught with multiple potential complica-
tions (4,5). Although extremely small for kidney trans-
plantation, and probably higher for the removal of seg-
ments of other vital organs, the incidence of donor death 
must be considered and reviewed in the greatest detail 
possible with each potential donor and the staff. The 
cumulative worldwide living-donor mortality for kidneys 
is below 0.1 % (3), but this mortality may be as high as 
1 % in donors of other organs. For the one donor who 
has succumbed to his supreme act of generosity, the 
mortality rises to 100%. The authors submit that these 
concerns and risks may be at the very least as relevant 
as the pressure of organ scarcity which constitutes the 
central motivation for living-organ transplantation. 
While there is no absolute justification for an elimi-
nation of the practice until alternative and equivalent 
sources of organs can be found, the authors are con-
cerned that much of the effort spent on living-organ trans-
plantation may unwittingly interfere with urgently neces-
sary progress in the retrieval and sharing of cadaver-
donor organs, and in the investigative efforts of search-
ing for potential animal sources of life-saving organs, ie, 
xenotransplantation (6). The authors admire the cour-
age and faith of the surgical teams and normal donor 
volunteers who are involved in living-organ donation. We 
are deeply concerned, however, with the potential haz-
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ard of proliferation of this part of clinical transplantation 
at the expense of other equally important therapeutic 
avenues, as well as the potentially devastating effects of 
a tragic outcome upon the donor, the donor's family, and 
the surgical team involved in the procedure. Failed liv-
ing-organ procedures may also have a major deleteri-
ous effect upon the perception of organ donation by the 
public at large, thereby exerting a counterproductive in-
fluence upon the central priority of the transplantation 
community, ie, to increase retrieval rates of cadaver-or-
gan donation. 
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